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Abstract  
 
Background: Early substance use (SU) in adolescence is known to be associated with an elevated risk 
of developing substance use disorders (SUD); it remains unclear though whether early SU is 
associated with more rapid transitions to SUD.  
Objective: To examine the risk and speed of transition from first SU (alcohol, nicotine, cannabis) to 
SUD as a function of age of first use.  
Methods: N = 3021 community subjects aged 14–24 years at baseline were followed-up prospectively 
over 10-years. SU and SUD were assessed using the DSM-IV/M-CIDI.  
Results: (1) The conditional probability of substance-specific SU-SUD transition was the greatest for 
nicotine (36.0%) and the least for cannabis (18.3% for abuse, 6.2% for dependence) with alcohol in 
between (25.3% for abuse; 11.2% for dependence). (2) In addition to confirming early SU as a risk 
factor for SUD we find: (3) higher age of onset of any SU to be associated with faster transitions to 
SUD, except for cannabis dependence. (4) Transitions from first cannabis use (CU) to cannabis use 
disorders (CUD) occurred faster than for alcohol and nicotine. (5) Use of other substances co-occurred 
with risk and speed of transitions to specific SUDs.  
Conclusion: Type of substance and concurrent use of other drugs are of importance for the association 
between age of first use and the speed of transitions to substance use disorders. Given that further 
research will identify moderators and mediators affecting these differential associations, these findings 
may have important implications for designing early and targeted interventions to prevent disorder 
progression.   
 
Keywords: Substance use disorder; Age; Initiation; Transition; Adolescence; Epidemiology   
 
 
 
1. Introduction  
 
Early onset of substance use (SU) is related to an elevated risk of substance use disorder 
(SUD) (Grant and Dawson, 1997; DeWit et al., 2000; Breslau et al., 1993; Chen et al., 
2005).Available data though suggest that the relationship is complex and our knowledge 
about the speed of transition from first use to DSMIV abuse or dependence in adolescence 
and particularly of age at first use and its relation to the speed of transitions for different 
substances is still limited (Chen et al., 2005). This is likely due to methodological factors (e.g. 
differences in definitions of early onset) and a deficit of prospective-longitudinal studies on 
SUD incidence in adolescence (Rehm et al., 2005).  
 
This paper investigates for various substances, whether early onset of SU is associated with a 
more rapid progression to SUD in adolescence and examines the role of concurrent other SU. 
Such information can enhance understanding of SUD development in adolescence and may 
provide crucial data about time periods in which intervention may be promising.  
 
There is little disagreement that early SU onset is associated with an increased risk of SUD. 
This has been shown for transitions from alcohol use to alcohol disorders (Nelson and 
Wittchen, 1998a; Brook et al., 2002; Grant and Dawson, 1997; DeWit et al., 2000), from 
nicotine use to nicotine dependence (Breslau et al., 1993), from cannabis use to cannabis 
dependence (Chen et al., 2005) and from any illicit SU to illicit SUD (Grant and Dawson, 
1998). Animal research has shown tendencies for more intensive SU and for SU in response 
to distressing events in younger subjects (Siegmund et al., 2005; Füllgrabe et al., 2007; 
Adriani et al., 2002). While the role of physiological and social factors for the transition to 
SUD in adolescents with early SU is not clear yet, these subjects may be at risk of more rapid 
transitions to SUD. Chen et al. (2005) have shown that a younger age of first cannabis use 
(CU)was associated with an elevated risk of cannabis dependence within the first 24-months 
after first CU. This may suggest more rapid transitions in those with early CU onset. 
However, subjects with early onset of alcohol use also had a higher risk of transition to 
alcohol disorders, but made the transition more slowly (DeWit et al., 2000). Anthony and 
Petronis (1995) reported similar findings for transition to illicit substance use problems and 
showed that the elevated risk in early onset users was independent of the time between first 
use and disorder onset.  
 
Differences between substances concerning the speed of transition from use to dependence, 
and from abuse to dependence, have been found in studies with subjects from the community 
(Wagner and Anthony, 2002) and from partially clinical samples (Ridenour et al., 2005). 
However, these studies do not exclusively cover adolescence and young adulthood and 
provide little information about transition from use to abuse and transitions to nicotine 
dependence. Differences between substances in speed of transition from use to dependence 
were evident in an adolescent sample consisting of largely males and offspring of parents 
withSUD(Ridenour et al., 2006).With this background and also with consideration of 
differences in drug policies between countries, it is pertinent to investigate these issues in a 
representative community sample from Germany.  
 
This present study investigates the speed of transition from first SU to abuse, and from first 
SU to dependence, for alcohol, cannabis, and nicotine using 10-year prospective-longitudinal 
data from a representative community sample from Germany. We also investigate the relation 
between age of onset of SU and the risk and speed of transition to SUD, taking into account 
concurrent other SU. The aims of the present study were:  
 
(1) to examine the transition time from first use to SUD for nicotine, alcohol and cannabis in 
adolescence;  
 
(2) to assess whether early use in adolescence is associated with a higher risk of transition, 
and shorter transition time, to abuse or dependence;  
 
(3) to assess whether concurrent use of other substances is associated with the risk and speed 
of transition.  
 
2. Methods  
 
2.1. Sample and overall design  
 
Data were collected as part of the EDSP study, a 10-year prospective-longitudinal community 
study on the course and risk-factors for SU and SUD of a stratified sample of N= 3021 
subjects aged 14–24 years at baseline. Because the study emphasized early developmental 
stages of psychopathology, individuals aged 14–15 years were sampled at twice the 
probability of those aged 16–21 years. Individuals aged 22–24 years were sampled at half the 
probability of those aged 16–21 years. Detailed descriptions of the sample, the study design 
and objective have been reported elsewhere (Lieb et al., 2000; Wittchen et al., 1998a). The 
baseline sample was drawn from metropolitan Munich (German government registries) in 
1994 and was followed-up over a 10-year period with up to three follow-up examinations. 
The baseline survey was conducted in 1995 (T0, N= 3021); the follow-up examinations were 
carried out approximately 1.6 years (T1, median interval since baseline, only for the younger 
cohort of N= 1228 subjects aged 14–17 years at baseline), 3.5 years (T2) and 8.2 years (T3) 
later. Response rates (proportions of the baseline sample) were 71% at T0 (N= 3021), 84.3% 
(N= 2548) at T2 and 73.2% (N= 2210) at T3. The retention rates (proportions of the sample of 
the preceding wave) were: 88.0% (T0–T1), 88.8% (T1–T2), and 79.4% (T2–T3) in the 
younger cohort and 84.8% (T0–T2) and 80.6% (T2–T3) in the older cohort. At T3, the age 
range was 21–34 years. We tested whether baseline alcohol, nicotine and cannabis use 
predicted attrition. In the younger cohort, CU at baseline was associated with dropout at T3 
(OR 0.66, 95% CI: 0.4–0.9, p = 0.015). In the older cohort, baseline nicotine use was 
associated with drop-out at T3 (OR 0.71, 95% CI: 0.5–0.9, p = 0.027).  
 
2.2. Diagnostic assessment  
 
At each assessment wave, participants were assessed with the baseline or respective follow-up 
computer-assisted versions of the Munich-Composite International Diagnostic Interview 
(DIA-X/M-CIDI) (Wittchen et al., 1998b; Wittchen and Pfister, 1997), an updated version of 
theWorld Health Organisation (WHO) CIDI (Wittchen and Semmler, 1990). The M-CIDI is a 
fully standardized diagnostic interview designed for epidemiological research (Wittchen et al., 
1998b) to assess symptoms, syndromes and diagnoses of 48 mental disorders along with 
information about onset and duration. The diagnoses presented in this article are based on the 
computerized M-CIDI/DSM-IV algorithms. The DIA-X/M-CIDI administration includes a 
respondent booklet that includes (e.g.) symptom and SU lists in order to help the participant in 
answering complicated symptom questions and dating age of onset. The test–retest reliability 
and validity of the DIA-X/M-CIDI diagnoses have been established (Reed et al., 1998; 
Wittchen et al., 1998b; Wittchen, 1994). Test–retest reliability was satisfactory for nicotine 
dependence (Kappa = 0.64), any drug disorder (Kappa = 0.64), and any alcohol disorder 
(Kappa = 0.78) (Wittchen et al., 1998b). Validity was established; for example for alcohol 
abuse (Kappa = 0.83) and for any drug disorder (Kappa = 0.64) (Lachner et al., 1998). The 
intra-class-coefficients were good for the age at which the first dependence criterion for 
nicotine dependence was met (ICC = 0.83) (Wittchen et al., 1998b), and for age at first use of 
nicotine (ICC = 0.83), alcohol (ICC = 0.96), and illicit substances (ICC = 1.00) (Lachner et 
al., 1998). All interviewers had received intensive 1-week training on the DIA-X/M-CIDI, 
followed by at least 10 closely monitored practice interviews at baseline and booster sessions 
before each subsequent wave.  
 
2.2.1. Assessment of SU and SUD. SU and SUD were assessed with the three separate DIA-
X/M-CIDI-sections for nicotine, alcohol, and medication and illicit substance use. Each 
section first establishes the quantity and frequency of SU along with age of onset and recency 
information. Diagnostic criteria are only assessed if criteria for minimal SU are met and, in 
the case of illicit substances, if participants are willing to answer these questions truthfully. 
Criteria for minimal SU were: (a) tobacco use at least once per day over a 1-month period; (b) 
at least regular alcohol consumption (at least three times a week or more than three standard 
drinks per drinking day during the past 12 months in subjects who had drunk on more than 12 
occasions in at least 1 year of their lives; applied for alcohol dependence); alcohol use on at 
least 13 occasions in a 12-month period (for alcohol abuse); (c) illicit SU more than four 
times. For alcohol dependence, we used two screening questions in order to include subjects, 
who did not meet the criterion described above but met the minimal use criteria in shorter 
periods. Participants were asked whether they would answer questions on illicit substances 
truthfully (commitment probe). Subjects who declined were excluded from analyses 
concerning illicit substances (87 subjects at T0, 17 subjects at T1, 20 subjects at T2, and 22 
subjects at T3; 146 subjects in all).  
 
The base rates for substances other than alcohol, nicotine, and cannabis were too low to allow 
for the statistical approaches used.  
 
The following use levels were considered: no use, any use, DSM-IV abuse, and DSM-IV-
dependence (abuse and dependence were non-hierarchical). In keeping with current 
nomenclature, DSM-IV abuse and dependence are analysed separately.  
 
2.3. Statistical analysis  
 
Data were weighted to account for different sampling probabilities at baseline according to 
age, and response rates at baseline varying over age, gender, and geographic region. The Stata 
Software package 9.2 (StataCorp., 2007) was used for all calculations and to compute robust 
variances, confidence intervals, and p-values (by applying the Huber–White sandwich matrix) 
required when basing analyses on weighted data (Royall, 1986). Cumulative lifetime 
incidence was generated using the LOCF (Last Observation Carried Forward) method, i.e. the 
information obtained until the last available assessment was taken into account. This allowed 
using information from subjects who dropped out of the study during the assessments. The 
Kaplan–Meier (Therneau and Grambsch, 2000) estimator was used to estimate the age-
dependent cumulative lifetime incidence of SU and SUD. Hereby, age of onset information 
was aggregated from the assessments by using the minimum age of onset reported. When 
comparing this approach to the use of the age of onset reported first, intraclass correlations 
were very high for age of onset of alcohol use (rho = 0.99), nicotine use (rho = 1.00), cannabis 
use (rho = 1.00), alcohol abuse (rho = 0.96), alcohol dependence (rho = 0.96), nicotine 
dependence (rho = 0.96), cannabis abuse (rho = 0.96), and cannabis dependence (rho = 0.99).  
 
Cox regressions were applied to assess overall differences in the risk of developing SUD over 
time between groups with different ages at onset of SU. We allowed for different curves 
according to age and gender (“stratified Cox regression”, Therneau and Grambsch, 2000). To 
assess whether group differences varied over time, the proportional hazard assumption was 
tested using Schoenfeld residuals (Therneau and Grambsch, 2000). When the assumption was 
violated, the interaction term covariate×number of years since SU was added to the model in 
order to improve the model fit and to assess how strongly the hazard ratios depended on time. 
Here, the model-based time-dependent hazard ratio equals HR (main effect of covariate)×HR 
(interaction effect of covariate)number of years. Again the proportional hazard assumption 
was tested using Schoenfeld residuals. If still a poor fit was found we determined time 
intervals between which the hazard ratios showed the highest differences in an exploratory 
way. We applied the model for each substance separately, i.e. for the transition from nicotine 
use to nicotine dependence. This was done to consider differences in the speed of transition to 
SUD between groups with different ages at onset of SU. In a second step of analysis, we 
adjusted the results for the presence of the use of other substances (alcohol, nicotine, 
cannabis, other illicit substances) prior to the SUD of the substance under consideration. All 
subjects who had used the substance and provided age of onset information (see below) were 
included in the analyses on the risk and speed of transition.  
 
Few subjects had not provided information on age of onset of SU and/or SUD. Data from 
these subjects could not be used in the discrete-time survival analyses. For analyses on risk 
and speed of the transition, complete age of onset information for SU and SUD was required. 
However, in some cases such information was missing (alcohol: N= 7 for abuse, N= 8 for 
dependence; nicotine: N= 10 for dependence; cannabis: N= 15 for abuse, N= 6 for 
dependence). In addition, a number of cases had reported onset of SUD as prior to onset of 
SU: 21 (2.9%) for alcohol abuse, 6 (1.9%) for alcohol dependence, 11 (1.3%) for nicotine 
dependence, 17 (5.7%) for cannabis abuse, and 6 (5.9%) for cannabis dependence 
(percentages refer to the total number of those who had the respective SUD and who had 
provided age of onset information for SU and SUD). These cases were therefore excluded 
from the Cox-regression analysis. It should be noted though that for incidence and prevalence 
rates as given in Section 3.1, no age of onset information was required and the subjects who 
had not provided this information were included in this part of the analysis.  
 
For the test of group differences, we only considered groups with at least N= 10 individuals. 
The time scale used to assess transitions between SU and SUD was the number of years since 
the onset of SU. Since cases with SU and SUD onset within the same 12-months period (i.e. 
length of transition = 0 years) are otherwise automatically excluded from the Cox-regression 
analysis, we shifted the time scale 1 year upwards to include all cases in the Cox regression, 
replacing 0 years by 1 year, 1 year by 2 years, and so on. This approach was not used for the 
curves in Figs. 1 and 2.  
 
A commonly used definition of early SU onset in adolescence is still lacking. A definition of 
early onset as onset in adolescence in comparison to adulthood may be problematic, since SU 
onset normally occurs in adolescence. As a result, we chose to use different definitions of age 
of onset in an exploratory way, taking into account each year of the high-risk phase for initial 
SU in adolescence as a threshold for early onset in adolescence in comparison to later onset. 
We defined the high-risk phase as the phase with the steepest increase in the survival curve 
for incident SU (see Section 3.2). For instance, for the high-risk phase for first alcohol use 
between age 10 and 16 years, we first defined early age of onset as ≤age 10 years and later 
age of onset as >age 10 years; then we stepwise shifted the limit between early vs. later onset 
of use from age 10 to 16 years.  
 
3. Results  
 
3.1. Baseline lifetime prevalence and cumulative lifetime incidence  
 
At baseline 94.5% reported any alcohol use, 76.3% any nicotine use and 33.9% any CU. At 
the end of the observation period, cumulative incidence rates for any SU were 97.7% for 
alcohol, 79.2% for nicotine, and 50.7% for cannabis. Baseline rates for SUD were 13.7% for 
alcohol abuse, 3.7% for cannabis abuse, 18.8% for nicotine dependence, 6.2% for alcohol 
dependence, and 1.5% for cannabis dependence. Cumulative incidences for SUD up to T3 
were 24.7% for alcohol and 9.3% for cannabis abuse, 28.5% for nicotine dependence, 11.0% 
for alcohol dependence, and 3.1% for cannabis dependence (table including total numbers 
available upon request).  
 
3.2. Age of onset  
 
Survival analyses were conducted to describe age of onset distributions. In the following text, 
the steepest increase in the survival curve is described. First alcohol use mainly occurs 
between ages 10 and 16 years, first nicotine use between ages 11 and 17 years, and first CU 
between ages 14 and 19 years. The main onset interval was age 14–18 years for alcohol and 
age 15–20 years for cannabis abuse. For dependence, the main onset interval was age 14–19 
years for nicotine, age 15–19 years for alcohol and age 15–18 years for cannabis (figures 
available upon request).  
 
3.3. Proportion and time length of transitions to SUD  
 
Up to T3, the conditional abuse rates were 25.3% (weighted percents) of alcohol users and 
18.3% of cannabis users. Conditional dependence rates were 36.0% for nicotine, 11.2% for 
alcohol and 6.2% for cannabis.  
 
Figs. 1 and 2 display the time lapses from first use to onset of abuse and from first use to 
onset of dependence for all subjects who developed the respective disorder. Cannabis abuse 
(N= 283) occurs earlier after first CU than alcohol abuse after first alcohol use (N= 713). 
Almost 30% of cases with cannabis abuse had occurred at 1 year after onset of CU, 50% at 2 
years, and 70% at 3 years. In comparison, 10% of all alcohol abuse cases had occurred at 1 
year after first alcohol use, 30% at 2 years, and 60% at 4 years. Only a few new cases of abuse 
occurred 10 years or more after onset of use of the respective substance. Transitions to 
cannabis dependence (N= 95) occurred more rapidly than transitions to nicotine dependence 
(N= 826) and to alcohol dependence (N= 313). 20% of all cases of cannabis dependence 
occurred during the first year after onset of CU, almost 60% had occurred at 2 years, and 70% 
at 3 years. In comparison, almost 20% of all cases of nicotine dependence had occurred at 1 
year after first nicotine use, 40% at 2 years, and almost 70% at 4 years. For alcohol 
dependence, almost 30% of all cases had occurred until 2 years after first alcohol use, 40% at 
3 years, and 50% at 4 years.  
 
3.4. Risk and speed of transition by age at first use  
 
We compared risk and speed of transition to SUD in late vs. early onset users using Cox 
regressions. The results are given in Table 1 (risk of transition) and Table 2 (speed of 
transition). Table 3 provides an explanatory summary of these results.  
 
Early onset of alcohol use was associated with a higher risk but also with a lower speed of 
transition to alcohol abuse and dependence. For nicotine, early onset of use was related to an 
elevated risk of nicotine dependence but later onset of use was associated with a more rapid 
transition. Subjects with early CU onset had an elevated risk of transition to cannabis abuse 
and dependence. CU onset later in adolescence was associated with an elevated risk of a more 
rapid transition to cannabis abuse. For cannabis dependence, no interaction with time was 
found.  
 
We also assessed the risk and speed of transition by exploring time periods with highest 
differences in hazard ratios; detailed information available upon request).With early onset 
defined as ≤age 14 years, later onset of use was associated with a higher risk of alcohol abuse 
during the first year after onset of alcohol use (HR 2.05, 95% CI: 1.4–2.9), but later onset 
users were less likely to develop the disorder in the following years (HR 0.52, 95% CI 0.4–
0.6). With early onset defined as ≤age 13 years, later onset users were more likely to develop 
alcohol dependence during the first 2 years after onset of use (HR 2.31, 95% CI: 1.3–3.9). 
Later onset of use was associated with a lower risk of the disorder in the following years (HR 
0.48, 95% CI: 0.3–0.7). Differences were not significant after 12 years after onset of use. 
Regarding transitions to nicotine dependence (with early onset defined as ≤age 17 years), the 
difference in risk was not significant during the first year after onset of use (HR 1.43, 95% CI: 
0.9–2.2). Thereafter, the risk of transition was lower for later onset users (HR 0.53, 95% CI: 
0.3–0.8). From 8 years after onset of use, differences were not significant (HR 0.84, 95% CI: 
0.2–3.0).  
 
3.5. Concurrent use of other substances  
 
As concurrent other SU may be associated with the risk and speed of transition to SUD we 
repeated the analysis adjusting for concurrent SU prior to the SUD under consideration (for a 
summary of the results see Table 3; detailed tables are available upon request).  
 
We found that nicotine, cannabis and other illicit substance use co-occurred with the risk of 
transition to alcohol abuse in later onset users. Differences in risk between very early and later 
onset users now became significant (overall difference (age of onset ≤10 years): HR 0.74, 
95% CI: 0.5–0.9; overall difference (age of onset ≤11 years): HR 0.69, 95% CI: 0.5–0.9; 
overall difference (age of onset ≤12 years): HR 0.75, 95% CI: 0.6–0.9).  
 
Also, nicotine, cannabis and other illicit substance use co-occurred with the risk and speed of 
transition to alcohol dependence in later onset users. Group differences in risk between early 
and later onset users were significant (overall difference (age of onset ≤10 years): HR 0.61, 
95% CI: 0.4–0.9; overall difference (age of onset ≤11 years): HR 0.67, 95% CI: 0.4–0.9; 
overall difference (age of onset ≤12 years): HR 0.68, 95%CI: 0.5–0.9; overall difference (age 
of onset≤13 years):HR 0.62, 95% CI: 0.4–0.8). In one step of the analyses, the hazard ratio for 
a more rapid transition in later onset users was not significant (interaction effect: HR main 
effect 0.98, HR interaction effect 0.89, 95% CI 0.80–1.00 (age of onset ≤13 years)).  
 
Alcohol, cannabis and other illicit substance use co-occurred with the risk of transition to 
nicotine dependence in later onset users (e.g. overall difference (age of onset ≤11 years): HR 
0.69, 95% CI: 0.5–0.9; overall difference (age of onset≤12):HR0.65, 95% CI: 0.5–0.8; overall 
difference (age of onset ≤13 years): HR 0.67, 95% CI: 0.5–0.8; overall difference (age of 
onset ≤14 years): HR 0.71, 95% CI: 0.6–0.8).  
 
For CUD, we found no changes in the results when controlling for alcohol, nicotine and other 
illicit substance use. For transitions to CUD, we repeated the analysis adjusting for alcohol 
abuse, alcohol dependence and nicotine dependence prior to onset of CUD. Also in this 
analysis there were no changes in results.  
 
In exploring time periods with maximal differences in hazard ratios, we found the following 
results: with early onset of use defined as age ≤14 years, later onset users were more likely to 
develop alcohol abuse during the first year after onset of alcohol use (HR 1.71, 95% CI: 1.1–
2.5), but later onset users were less likely to develop the disorder in the following years (HR 
0.49, 95% CI: 0.3–0.6). For transitions to alcohol dependence (early onset defined as ≤13), no 
difference in risk during the first 2 years after onset of use was found (HR 1.58, 95% CI: 0.9–
2.7). After this point, subjects with later onset of use were less likely to develop dependence 
(HR 0.42, 95% CI: 0.3–0.6). The difference in risk of transition to nicotine dependence (early 
onset defined as ≤17) was not significant during the first year after onset of use (HR 1.03, 
95% CI: 0.6–1.6). Thereafter, the risk of transition was lower for later onset users (HR 0.50, 
95% CI: 0.3–0.8).  
 
4. Discussion  
 
Using data from a prospective-longitudinal community study, including the high-risk phase of 
SU and SUD in adolescence and early adulthood we described the transition times from first 
use (of alcohol, nicotine, and cannabis) to abuse of, and to dependence on these substances. In 
addition, we investigated the association between early SU onset and the risk and speed of 
transition to SUD. Each year of the high-risk phase of SU onset in adolescence was taken into 
account for a definition of early onset of use. The main findings are: (1) conditional SUD 
rates are highest for nicotine and lowest for cannabis. (2) The duration of transition from first 
SU to SUD is shortest for cannabis. (3) SU onset early in the high-incidence phase of SU in 
adolescence is associated with an elevated risk of SUD for all the substances. (4) SU onset 
later in adolescence is associated with a more rapid progression to SUD for alcohol abuse and 
dependence, nicotine dependence and cannabis abuse. (5) For subjects with later onset of SU, 
concurrent other SU is related to the increased risk of SUD (for alcohol and nicotine) and the 
increased speed of transition to alcohol dependence.  
 
Our paper confirms adolescence as the core high-incidence phase for first SU and SUD as 
reported from earlier stages of our study (Lieb et al., 2000; Perkonigg et al., 2006a, 1999; von 
Sydow et al., 2001; Nelson and Wittchen, 1998a,b) and other studies (Fergusson et al., 2006; 
Chen and Kandel, 1995; Boden et al., 2006; Costello and Erkanli, 1999; Monshouwer et al., 
2005; Wagner and Anthony, 2002). We also confirm early SU onset as a risk factor for SUD. 
We extend these findings by examination of substance-specific differences in speed of 
transitions, the role of age in the speed of transitions, and the role of concurrent SU.  
 
4.1. Speed of transition from first SU to SUD  
 
We found that transitions to cannabis abuse and dependence occurred more rapidly than 
transitions to alcohol disorders and nicotine dependence. Thus far, this had only been 
observed for transitions to cannabis dependence in a study in which males and subjects with a 
parent with SUD were over-sampled (Ridenour et al., 2006). The similarity is interesting, 
since it occurred in spite of different sampling strategies and drug policies.  
 
The finding of relatively rapid transitions to CUD seems inconsistent with the view that 
cannabis has little addictive potential (Nocon et al., 2006). However, conditional disorder 
rates were smallest for cannabis. This is surprising because the speed of transition and the 
proportion of transitions to cannabis dependence were consistent in a study with adolescents 
(Ridenour et al., 2006). This difference may be due to the different sampling strategies. As 
suggested by Ridenour et al. (2006), proportion and speed of transitions should be taken into 
account when measuring addictive liability. Our results raise the question why a small but 
considerable number of cannabis users made this fast transition. Factors that may account for 
this pattern will be discussed further below.  
 
4.2. Age of onset of SU  
 
Including the high-incidence phase of SU and SUD in adolescence, we show that SU early in 
adolescence is associated with an elevated risk of SUD for alcohol, nicotine and cannabis. 
The elevated risk occurred independent of time between first use and SUD as shown by Sung 
et al. (2004) and Anthony and Petronis (1995) for more general SU/SUD categories. Our 
findings suggest that differentiation between early and late onset in adolescence is a 
meaningful alternative to the differentiation between onset in adolescence and onset in 
adulthood. SU onset later in adolescence was associated with a more rapid progression to 
SUD (with the exception of cannabis dependence). These findings suggest that an elevated 
risk of transition does not necessarily accompany an elevated speed of transition.  
 
4.3. Transitions to alcohol disorders  
 
Similar to DeWit et al. (2000), we found a higher risk and a lower speed of transition to 
alcohol disorders in those with early onset of alcohol use. Since risk and speed of transitions 
to alcohol dependence in later onset users co-occurred with other SU, transitions to alcohol 
use disorders in late adolescence may be influenced by other SU experiences.  
 
The higher speed of transition in later onset users may also be due to the emergence of more 
intense drinking patterns (Reboussin et al., 2006), less alcohol related parental control (van 
Zundert et al., 2006) and greater opportunities to obtain alcohol in late adolescence. 
Interestingly, in animal studies examining the development of ethanol intake, a latency period 
of less ethanol consumptionwas observed in adolescent vs. adult rats after first ethanol use. 
After this period, the consumption of the younger rats reached the level of the adult animals 
(Siegmund et al., 2005). Early onset may contribute to vulnerability to factors occurring after 
onset of use. For example, rats with first ethanol consumption in adolescence as compared to 
adulthood showed a greater increase in ethanol consumption after stressful events (Siegmund 
et al., 2005; Füllgrabe et al., 2007). This may explain the combination of a greater risk and a 
slower transition in early onset users.  
 
4.4. Transitions to nicotine dependence  
 
Similar to Breslau et al. (1993), we found no difference in risk of transition to nicotine 
dependence for very early onset users in the unadjusted model. In our sample, the risk of 
transition of later onset users co-occurred with other SU. Adjustment for other SU revealed an 
elevated risk for nicotine dependence for those with very early onset. The elevated risk of a 
more rapid transition to nicotine dependence in later onset users may be explained by higher 
social acceptance and more opportunities of regular smoking in late adolescence. Later onset 
of smoking is associated with a faster transition to daily smoking (Breslau et al., 1993). This 
is somewhat in contrast to animal research that has shown greater nicotine self-administration 
in rats with onset of nicotine use in adolescence (Levin et al., 2003) and in mice in early vs. 
later adolescence (Adriani et al., 2002). On the other hand, mice in early adolescence show a 
distinct but delayed compensatory reaction when confronted with reduced nicotine 
concentration in a solution. Also, proximal behaviour outcomes of nicotine consumption 
differed in early vs. late adolescent mice (Adriani et al., 2002). Effects of nicotine are possibly 
experienced as more pleasant in late adolescence, which would explain the more rapid 
transitions in late adolescence. Also, nicotine withdrawal was more distinct in adult rats 
(O’Dell et al., 2006), a phenomenon that could be related to more rapid transitions later in 
human adolescence.  
 
4.5. Transitions to CUD  
 
We confirmed early onset of CU as a risk-factor for CUD, but early use was not associated 
with a more rapid transition to CUD. In a study of Chen et al. (2005) early onset of use was 
associated with an elevated risk of dependence within 24 month after first CU. This may be 
due to the risk of transition associated with early CU onset and the high speed of transitions to 
CUD. The age-risk association may be related to an increase in adverse effects of cannabis 
with age, a phenomenon that has been described in animal research (Schramm-Sapyta et al., 
2007). Also, those who developed CUD after early CU onset may be particularly vulnerable 
because of other factors as for example other mental disorders associated with CU and CUD 
(Wittchen et al., 2007).  
 
4.6. Implications for interventions  
 
Our findings have several implications for interventions. Early onset users are at an elevated 
risk of SUD, even if the transition may not be immediate. Careful attention should be paid to 
factors that may “trigger” transitions to SUD in early onset users. Interventions should take 
into account the speed of transitions to CUD, and the speed of transitions in later onset users. 
As a result, simply delaying first use may not be a sufficiently promising intervention for 
SUD. However, delaying first SU is important because early SU is a risk-factor for SUD. 
Primary prevention approaches addressing behaviour problems in first grade are associated 
with a decreased risk of nicotine, but not of alcohol, inhalant and cannabis use by age 14 years 
(Furr-Holden et al., 2004). Interventions should also address concomitant SU as it is related to 
the risk and speed of transitions. Given that at least one-time alcohol, nicotine and cannabis 
use is widespread in this sample, secondary prevention aimed at transitions to regular use is 
important. Of particular concern is that subjects with regular legal SU, but no SUD, had low 
service use rates (Perkonigg et al., 2006b). Other strategies to reach this population before the 
transition to SUD are necessary.  
 
4.7. Implications for future research  
 
Other areas of future investigation include the relation of other factors to SU patterns, and 
other vulnerabilities and risk factors associated with the risk and speed of transitions. Future 
research should investigate whether early onset of SU is a general marker for problematic 
development, a moderator, or a mediator moderated by for example early developmental 
problems.  
 
It is of interest to identify general and substance-specific factors that may be associated with 
risk in comparison to timing, i.e. speed of transition. Also, further differences between later 
and early onset users have to be identified. For example, family history (e.g. parental mental 
disorder) and mental disorders in adolescence are associated with CU initiation and 
progression (von Sydow et al., 2002; Höfler et al., 1999; Wittchen et al., 2007); but their 
association with the speed of transition remains to be investigated in representative samples. 
Early and late onset users may differ with regard to associated mental disorders, family 
genetic factors and personality traits (Sung et al., 2004; Obot et al., 2001; Costello and 
Erkanli, 1999; Elkins et al., 2006). Parental SU may function as a role model for adolescent 
SU (Alati et al., 2005; van Zundert et al., 2006) and thus influence the risk and speed of 
transitions. Most incident cases of SUD occur during a period with important developmental 
tasks, for example finishing school. Experience of low control in the work place in 
adolescence is prospectively associated with substance dependence (Reed et al., 2006) and 
may be associated with the higher speed of transitions in late adolescence.  
 
Here, we investigated substance-specific transitions (e.g. from nicotine use to nicotine 
dependence), but in future research, it would be interesting to investigate whether early use of 
one substance is associated with the development of SUD related to another substance. Also, 
in keeping with current nomenclature, we analysed DSM-IV abuse and dependence 
separately. However, there is evidence that DSM-IV abuse and dependence may not be 
separable constructs (Saha et al., 2006). In future research, the two categories could be 
collapsed into one. With regard to our results on the incidence periods of SU and SUD and the 
speed of transitions, frequency and duration of exposure alone are probably not a sufficient 
explanation. Other factors as social and cognitive affective developmental stages and periods 
of genetically determined increased vulnerability may be additional explanations. However, 
our study was not designed to address these important issues in sufficient detail.  
 
4.8. Limitations  
 
The age range of the sample restricted this analysis. SUD may occur later in life. Yet, results 
from this sample aged 21–34 years at the final wave suggest that SU and SUD incidence 
rarely occurs after age 20 years. This analysis did not investigate the role of other mental 
disorders and of different SU patterns, but this will be addressed in future analyses. The time 
difference between assessment waves is fairly large. We used retrospective age of onset 
information between waves, which may be subject to recall bias. In spite of high retention 
rates in general, baseline CU and nicotine use were associated with drop-out at T3. It cannot 
be ruled out that some especially severe cases were not considered in the analysis. The sample 
is from metropolitan Munich, a relatively wealthy German region with relatively liberal 
legislation on alcohol and nicotine use, but strictly enforced legislation on illegal drug use. 
These factors may have affected the observed SU behaviour in a complex way. Thus, results 
may not be generalizable to other populations with greater variation in SES and ethnicity. In 
this regard it is of importance that overall, onset of SU did not occur earlier in our sample than 
in US samples (Vega et al., 2002; Chen et al., 2005; Everett et al., 1999), with the exception 
that onset of alcohol use occurred later in the NESARC (Hingson et al., 2006). This difference 
may be due to cohort effects and different study designs. Finally it remains open whether 
associations between SU onset and the speed of transitions can also be confirmed on the level 
of SUD symptoms. The function of DSM-IV criteria may vary with age (Saha et al., 2006), 
and certain first symptoms may be especially prevalent in adolescents (Holly et al., 1997), 
even after minimal SU (Chen and Anthony, 2003).  
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